BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3006393)

  • 1. [Cytomorphology and prognosis of invasive breast cancer--recommendation for cytologic grading and personal experiences].
    Schöndorf NK; Neis KJ; Gräber S
    Verh Dtsch Ges Pathol; 1985; 69():532-6. PubMed ID: 3006393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic significance of tumor grading in breast cancer].
    Reiner A; Holzner JH; Reiner G; Spona J; Schemper M; Kolb R; Jakesz R
    Verh Dtsch Ges Pathol; 1985; 69():365-9. PubMed ID: 3006387
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study.
    Mouriquand J; Pasquier D
    Acta Cytol; 1980; 24(2):153-9. PubMed ID: 6245554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of methods of diagnosing breast cancer].
    Gest J
    Nouv Presse Med; 1982 Apr; 11(17):1295-7. PubMed ID: 6281723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
    Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
    Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraductal, lipid forming histiocytoid breast cancer. Contribution to the differential diagnosis of intraductal lipophage proliferations].
    Jäger J; Bässler R
    Pathologe; 1991 Jan; 12(1):44-7. PubMed ID: 1850829
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
    Richter-Ehrenstein C; Müller S; Noske A; Schneider A
    Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic influence of incisional biopsy or excisional biopsy in breast cancer patients treated by radical mastectomy].
    Su Y; Rui JA; Wang CF
    Zhonghua Wai Ke Za Zhi; 1987 Oct; 25(10):573-5, 612. PubMed ID: 2835214
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 13. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinico-diagnostic and therapeutic considerations in carcinoma of the male breast].
    Martino G; Corbelli GC; Pascarella G; Zelli GP
    G Chir; 1993 Jan; 14(1):45-50. PubMed ID: 8386929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M; Bachmann FF
    Med Welt; 1982 Jul; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytological changes in breast carcinoma in situ].
    Stosiek U; Breitbach GP
    Zentralbl Gynakol; 1984; 106(6):407-10. PubMed ID: 6326431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of breast cancer].
    Mohr HJ; Mainzer FG
    Pathologe; 1980 Nov; 2(1):44-7. PubMed ID: 6258169
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastatic behavior of breast cancer correlated with TNM classification and malignancy grade. An autopsy study].
    Kunze E; Eiardt B; Reckels M
    Verh Dtsch Ges Pathol; 1985; 69():322-6. PubMed ID: 3006383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytodiagnosis of invasive ductal breast cancer].
    Finsterer H
    Verh Dtsch Ges Pathol; 1985; 69():502-7. PubMed ID: 3006391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.